NCT00059878View on ClinicalTrials.gov

Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2003

Study Completion Date

January 31, 2005

Conditions

InfectionUnspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL

recombinant interferon gamma

DRUG

voriconazole

Trial Locations (3)

72205

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock

32610-100277

Shands Cancer Center at the University of Florida Health Science Center, Gainesville

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00059878 - Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections | Biotech Hunter | Biotech Hunter